The landscape of American healthcare in 2026 continues to be defined by a widening gap between the cost of medical services and the average consumer’s ability to pay, a trend that has forced a significant reimagining of employee benefits. Recent data from KFF indicates a sobering reality for the national workforce: approximately 75% of uninsured adults in the United States reported skipping or postponing essential medical care in 2025 due to prohibitive costs. Even for those with coverage, the financial burden remains heavy, with half of U.S. adults reporting difficulty affording healthcare and 30% struggling to settle medical bills within the past twelve months. As out-of-pocket expenses—including deductibles, copayments, and coinsurance—reach record highs, employers are increasingly turning to tax-advantaged reimbursement models to retain talent and ensure the health of their workforce.
Understanding the Architecture of Out-of-Pocket Costs
To address the financial strain on employees, it is first necessary to define what constitutes "out-of-pocket" spending in the current regulatory environment. These costs represent the portion of medical expenses that health insurance does not cover, regardless of whether the policy is employer-sponsored, purchased through the Affordable Care Act (ACA) Marketplace, or obtained via private off-exchange markets.
The primary components of these costs include deductibles—the amount an individual must pay before their insurance begins to cover costs; copayments—fixed fees for specific services such as office visits or prescriptions; and coinsurance—the percentage of costs an individual pays after the deductible is met. For the 2026 plan year, the Internal Revenue Service (IRS) has set the maximum out-of-pocket limit at $10,600 for individual policies and $21,200 for family policies. These limits, however, typically only apply to in-network care. When employees seek out-of-network services or require treatments not classified as "essential health benefits," their financial exposure can far exceed these statutory caps.
The Chronological Evolution of Reimbursement Benefits
The shift toward medical expense reimbursement is not a sudden phenomenon but the result of a decade-long evolution in federal policy and market demand. Historically, the "one-size-fits-all" group health insurance model dominated the corporate world. However, the rising cost of premiums—which have consistently outpaced inflation—led to the development of more flexible alternatives.
In 2016, the 21st Century Cures Act introduced the Qualified Small Employer Health Reimbursement Arrangement (QSEHRA), allowing small businesses to reimburse employees for health insurance premiums and medical expenses tax-free. This was followed in 2020 by the expansion of Individual Coverage HRAs (ICHRAs), which allowed businesses of all sizes to move away from managed group plans entirely, instead providing employees with tax-free funds to purchase their own individual policies. By 2026, these models have become mainstream, reflecting a broader transition from "defined benefit" healthcare to "defined contribution" healthcare, mirroring the shift from traditional pensions to 401(k) plans in previous decades.
Reimbursable Health Expenses Under IRS Section 213(d)
A critical component of modern benefit design is the utilization of IRS Publication 502, which outlines more than 200 types of medical expenses eligible for reimbursement. These are often referred to as Section 213(d) expenses. For employees managing chronic conditions—such as diabetes, hypertension, or autoimmune disorders—the ability to use tax-free employer funds for these items is a vital financial lifeline.
Commonly reimbursable expenses include:
- Prescription Medications: Both brand-name and generic drugs required for treatment.
- Specialized Care: Fees for surgeons, obstetricians, psychiatrists, and physical therapists.
- Diagnostic Tools: Laboratory tests, X-rays, and imaging services like MRIs.
- Ancillary Services: Dental treatments, vision care (including exams, glasses, and contact lenses), and hearing aids.
- Medical Equipment: Devices such as crutches, wheelchairs, and blood sugar monitoring kits.
By leveraging Health Reimbursement Arrangements (HRAs), Health Savings Accounts (HSAs), or Flexible Spending Accounts (FSAs), employers can ensure that employees are not forced to choose between financial stability and necessary medical interventions.
Strategic Implementation: HRAs vs. Health Stipends
Employers looking to mitigate the impact of out-of-pocket costs generally choose between two primary mechanisms: the Health Reimbursement Arrangement (HRA) and the health stipend. Each offers distinct advantages and regulatory challenges.
The HRA Advantage
HRAs are employer-funded accounts that reimburse employees for qualifying medical expenses. The most significant advantage of an HRA is its tax status; all reimbursements are 100% tax-free for both the employer and the employee. This means that every dollar committed by the company goes directly toward the employee’s health needs without being eroded by payroll or income taxes.
Modern HRAs offered by administrators like PeopleKeep and Remodel Health include:
- The ICHRA (Individual Coverage HRA): A versatile tool for businesses of any size that replaces traditional group insurance with a monthly allowance for individual premiums and out-of-pocket costs.
- The QSEHRA (Qualified Small Employer HRA): Specifically designed for companies with fewer than 50 full-time equivalent employees who do not offer a group plan.
- The Group Integrated HRA: Designed for employers who still offer a traditional group plan but want to provide additional funds to help employees cover the high deductibles associated with those plans.
The Role of Health Stipends
For organizations seeking maximum simplicity and fewer regulatory hurdles, health stipends provide a viable, albeit less tax-efficient, alternative. A stipend is a fixed amount of money added to an employee’s paycheck to help with healthcare costs. Unlike HRAs, stipends do not require employees to provide receipts or proof of insurance, and there are no restrictions on what the money can be used for.
However, from a journalistic and financial analysis perspective, stipends carry a "tax penalty." Because they are treated as gross income, they are subject to standard income and payroll taxes. Furthermore, for "Applicable Large Employers" (those with 50 or more employees), a stipend does not satisfy the ACA’s employer mandate, potentially exposing the company to significant penalties if employees seek subsidies on the health insurance exchange.
Market Analysis: The Impact on Recruitment and Retention
In the competitive labor market of 2026, health coverage remains the most requested benefit among employees. The shift toward reimbursement models represents a fundamental change in the "social contract" between employer and employee. Industry analysts suggest that by offering an HRA, employers are moving toward a "personalization" of benefits. Rather than providing a single plan that may not suit a diverse workforce, an HRA allows a 25-year-old single employee to use funds for mental health and preventative care, while a 50-year-old employee with a family can use the same funds for orthodontic work and chronic disease management.
Data suggests that companies offering flexible reimbursement options see higher retention rates. When employees feel that their specific medical needs are supported without the "cliff" of a $10,000 out-of-pocket maximum looming over them, their loyalty to the organization increases. Moreover, these models provide employers with budget predictability. In a traditional group plan, a single catastrophic health event within the company can lead to a 20% or 30% premium hike the following year. With an HRA, the employer sets a fixed contribution, protecting the company’s bottom line from the volatility of the healthcare market.
Implications for the Future of Corporate Wellness
As we look toward the remainder of the decade, the integration of technology and benefit administration is expected to deepen. The rise of platforms that automate the verification of medical receipts and ensure compliance with ever-changing IRS regulations has lowered the barrier to entry for small and medium-sized enterprises (SMEs).
The broader implication of this trend is a more resilient healthcare consumer. When out-of-pocket costs are managed through employer contributions, the "delay of care" phenomenon highlighted by KFF is mitigated. This, in turn, leads to a healthier workforce with fewer long-term complications from untreated conditions, ultimately reducing the total cost of care for the entire economy.
Conclusion
The escalation of out-of-pocket medical costs is a systemic challenge that requires a strategic response from the private sector. While the 2026 limits of $10,600 and $21,200 represent a significant financial hurdle for the average American household, the emergence of HRAs and health stipends offers a path forward. By understanding the nuances of IRS Section 213(d) and selecting the appropriate reimbursement vehicle, employers can transform a significant financial burden into a competitive advantage, ensuring that their team members are both physically healthy and financially secure. The transition from traditional insurance to personalized reimbursement is not merely a fiscal adjustment; it is a necessary evolution in the pursuit of a sustainable healthcare ecosystem.
